Sandbox Reserved 707: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 38: | Line 38: | ||
'''2.''' In the large lobe, the activation segment can make or break part of the ATP binding site.<br /> | '''2.''' In the large lobe, the activation segment can make or break part of the ATP binding site.<br /> | ||
The activation segment of each protein kinase has a specific domain that begins with a DFG amino acid sequence that can easily change its conformation (active or inactive conformation). In the inactive conformation the phenylalanine side chain occupies the ATP binding pocket and the aspartate side chain faces away from the active site. This is the DFG Aspartate '''Out''' Conformation. In the active conformation, the phenylalanine side chain is rotated out of the ATP binding pocket and the Aspartate side chain can now face the ATP binding pocket and form coordinated links with the Mg²⁺. This is called the DFG Aspartate '''In''' Conformation. The activation segment can be phosphorylated by members of the same protein kinase family or by other protein kinases. <br /> | The activation segment of each protein kinase has a specific domain that begins with a DFG amino acid sequence that can easily change its conformation (active or inactive conformation). In the inactive conformation the phenylalanine side chain occupies the ATP binding pocket and the aspartate side chain faces away from the active site. This is the DFG Aspartate '''Out''' Conformation. In the active conformation, the phenylalanine side chain is rotated out of the ATP binding pocket and the Aspartate side chain can now face the ATP binding pocket and form coordinated links with the Mg²⁺. This is called the DFG Aspartate '''In''' Conformation. The activation segment can be phosphorylated by members of the same protein kinase family or by other protein kinases. <br /> | ||
A gatekeeper residue separates the adenine binding site from the hydrophobic pocket. Mutation on this residue can prevent the binding of kinase inhibitory drugs (the replacement of a threonine by a methionine for example).<br /> | A <scene name='Sandbox_Reserved_707/Gatekeeper_residue/1'>gatekeeper residue</scene> separates the adenine binding site from the hydrophobic pocket. Mutation on this residue can prevent the binding of kinase inhibitory drugs (the replacement of a threonine by a methionine for example).<br /> | ||
| Line 62: | Line 62: | ||
|'''14-3-3 binding site''': || S365-S729 | |'''14-3-3 binding site''': || S365-S729 | ||
|- | |- | ||
|'''Gatekeeper Residue''': || T529 | |'''<scene name='Sandbox_Reserved_707/Gatekeeper_residue/1'>Gatekeeper Residue</scene>''': || T529 | ||
|- | |- | ||
|'''HRD''': || 574-576 | |'''HRD''': || 574-576 | ||
